![Esther Rajavelu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Esther Rajavelu
Vorstandsvorsitzender bei
SPERO THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 31.08.2026
Profil
Esther Rajavelu is currently President, CEO, CFO, Treasurer & Director at Spero Therapeutics, Inc. since 2025.
Former positions include Chief Financial Officer & Treasurer at Fulcrum Therapeutics, Inc. from 2022 to 2023; Senior Equities Research Analyst at UBS Securities LLC from 2020 to 2022; Executive Director & Senior Analyst at Oppenheimer & Co., Inc. (Broker) from 2018 to 2020; Research Analyst at Deutsche Bank Securities, Inc. from 2014 to 2018; Vice President-Life Sciences at Ernst & Young Capital Advisors LLC from 2011 to 2014; Vice President at Merrill Lynch, Pierce, Fenner & Smith, Inc.; Analyst at J.P.
Morgan & Co., Inc. (Old); Associate at Towers Perrin Capital Markets, Inc. Education includes undergraduate degree from Wesleyan University and MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.05.2026 | 986’851 ( 1.69% ) | 1 Mio $ | 31.08.2026 |
Aktive Positionen von Esther Rajavelu
| Unternehmen | Position | Beginn |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Vorstandsvorsitzender | 10.01.2025 |
Ehemalige bekannte Positionen von Esther Rajavelu
| Unternehmen | Position | Ende |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Finanzdirektor/CFO | 21.04.2023 |
UBS Securities LLC
 UBS Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.01.2022 |
Oppenheimer & Co., Inc. (Broker)
 Oppenheimer & Co., Inc. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.01.2020 |
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.06.2018 |
Ernst & Young Capital Advisors LLC
 Ernst & Young Capital Advisors LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01.01.2014 |
Ausbildung von Esther Rajavelu
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
92
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
UBS Securities LLC
UBS Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Towers Perrin Capital Markets, Inc. | |
J.P. Morgan & Co., Inc. (Old)
 J.P. Morgan & Co., Inc. (Old) Regional BanksFinance Provides commercial banking and investment advisory services | Finance |
Oppenheimer & Co., Inc. (Broker)
Oppenheimer & Co., Inc. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Wesleyan University
 Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
 Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Ernst & Young Capital Advisors LLC
Ernst & Young Capital Advisors LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fulcrum Therapeutics, Inc.
 Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
